Gundersen expands treatment for enlarged prostate with revolutionary UroLift® System
Your patients with enlarged prostate, or benign prostatic hyperplasia (BPH), now have another treatment option at Gundersen Health System: the revolutionary UroLift® System.
This minimally invasive approach to treatment provides rapid symptom relief for men 45 and older while reducing the need for medications and avoiding major surgery. UroLift also is the only BPH procedure shown not to cause new and lasting erectile or ejaculatory dysfunction.
The UroLift System uses a permanent implant to lift and hold your patient's enlarged prostate so it no longer blocks the urethra. It is the only available BPH treatment performed by a urologist that does not require heating, cutting or removal of tissue. The procedure is typically performed using local anesthesia, allowing your patients to return home the same day without a catheter.
BPH affects more than 40 million Americans. While the condition is benign and unrelated to prostate cancer, it can limit quality of life. As the prostate enlarges, it puts pressure on the urethra, causing urinary symptoms such as:
- A frequent need to urinate during the day and at night
- A weak or slow urinary stream
- A sense that you cannot completely empty your bladder
- Difficulty or delay in starting urination
- An urgent feeling of needing to urinate
- A urinary stream that stops and starts
For more information about the UroLift System or to make a referral, contact MedLink at (800) 336-5465 or (608) 775-5465 in La Crosse.